Terminalcare Support Institute, Inc. (JP:7362)
:7362
Top Page
Terminalcare Support Institute, Inc.
(7362)
Select Model
Select Model
Rating:49Neutral
Price Target:
¥812.00
▲(1.63% Upside)
Action:ReiteratedDate:02/18/26
The score is held back primarily by weakening profitability, rising leverage, and sustained negative free cash flow, which together elevate financial risk. Technical indicators are mildly supportive and valuation appears moderate, but these are not strong enough to offset the financial pressure.
Positive Factors
Consistent Revenue Growth
Sustained top-line growth across 2020–2025 indicates durable demand and expanding service penetration in its care facilities business. Persistent revenue expansion supports scale economics and provides a base for margin recovery and reinvestment even if profitability is pressured.
Negative Factors
Rising Leverage
A material increase in leverage over a few years reduces financial flexibility and raises interest and refinancing risk. Higher debt loads magnify the impact of any future operating setbacks and constrain the firm’s ability to invest organically or pursue opportunistic M&A without raising costly external capital.
Read all positive and negative factors
Positive Factors
Negative Factors
Consistent Revenue Growth
Sustained top-line growth across 2020–2025 indicates durable demand and expanding service penetration in its care facilities business. Persistent revenue expansion supports scale economics and provides a base for margin recovery and reinvestment even if profitability is pressured.
Read all positive factors
Terminalcare Support Institute, Inc. (7362) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥1.25B
Dividend YieldN/A
Average Volume (3M)1.68K
Price to Earnings (P/E)14.8
Beta (1Y)0.43
Revenue Growth2.81%
EPS Growth-42.50%
CountryJP
Employees451
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)37.97
Shares Outstanding1,533,100
10 Day Avg. Volume2,080
30 Day Avg. Volume1,683
Financial Highlights & Ratios
PEG Ratio-0.52
Price to Book (P/B)0.86
Price to Sales (P/S)0.25
P/FCF Ratio-1.76
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Terminalcare Support Institute, Inc. Business Overview & Revenue Model
Company Description
Terminalcare Support Institute Inc. provides home-visit care, preventive care, home-care support, and home-visit nursing services in Japan. It also offers housing for the elderly services. The company was founded in 2010 and is headquartered in Ky...
How the Company Makes Money
Terminalcare Support Institute, Inc. generates revenue through multiple streams, including tuition fees from training and certification programs offered to healthcare professionals, consultation fees for personalized care strategy development, and...
Terminalcare Support Institute, Inc. Financial Statement Overview
Summary
Income Statement
56
Neutral
Balance Sheet
44
Neutral
Cash Flow
29
Negative
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.78B | 4.89B | 4.71B | 4.25B | 4.10B | 3.40B |
| Gross Profit | 651.77M | 626.27M | 664.67M | 646.76M | 685.84M | 599.50M |
| EBITDA | 240.34M | 205.09M | 250.59M | 196.83M | 262.62M | 247.27M |
| Net Income | 86.90M | 81.97M | 113.77M | 126.67M | 157.54M | 138.03M |
Balance Sheet | ||||||
| Total Assets | 5.32B | 5.81B | 4.80B | 4.09B | 3.05B | 2.89B |
| Cash, Cash Equivalents and Short-Term Investments | 887.13M | 1.19B | 1.13B | 1.38B | 1.09B | 874.72M |
| Total Debt | 3.26B | 3.58B | 2.81B | 2.26B | 1.22B | 1.43B |
| Total Liabilities | 4.00B | 4.39B | 3.49B | 2.90B | 1.96B | 1.96B |
| Stockholders Equity | 1.32B | 1.41B | 1.31B | 1.19B | 1.08B | 927.37M |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -691.25M | -780.73M | -562.25M | 317.64M | -56.66M |
| Operating Cash Flow | 0.00 | 287.23M | 304.51M | 238.18M | 812.73M | 462.19M |
| Investing Cash Flow | 0.00 | -1.01B | -1.10B | -836.33M | -510.68M | -523.54M |
| Financing Cash Flow | 0.00 | 771.09M | 545.64M | 892.46M | -90.11M | 523.02M |
Terminalcare Support Institute, Inc. Technical Analysis
Positive
799.00
Price Trends
806.28
Positive
804.52
Positive
818.59
Negative
Market Momentum
2.95
Negative
53.03
Neutral
55.69
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7362, the sentiment is Positive. The current price of 799 is below the 20-day moving average (MA) of 811.55, below the 50-day MA of 806.28, and below the 200-day MA of 818.59, indicating a neutral trend. The MACD of 2.95 indicates Negative momentum. The RSI at 53.03 is Neutral, neither overbought nor oversold. The STOCH value of 55.69 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7362.
Terminalcare Support Institute, Inc. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥2.92B | 4.69 | ― | 2.82% | 4.82% | 9.78% | |
74 Outperform | ¥2.83B | 27.02 | ― | 2.56% | -3.06% | -38.56% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | ¥5.89B | 23.20 | ― | 4.07% | 6.08% | 38.00% | |
49 Neutral | ¥1.25B | 14.80 | ― | ― | 2.81% | -42.50% | |
45 Neutral | ¥6.49B | 33.86 | ― | 1.41% | 18.03% | -11.68% |
* Healthcare Sector Average
JP:7362
Terminalcare Support Institute, Inc.
821.00
63.00
8.31%
JP:2373
Care Twentyone Corporation
436.00
61.14
16.31%
JP:2425
Care Service Co., Ltd.
747.00
-5.39
-0.72%
JP:7061
Japan Hospice Holdings Inc.
761.00
-727.10
-48.86%
JP:9220
FB CARE SERVICE CO.,LTD.
1,198.00
317.40
36.04%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.